Eric Ostertag

4.8k total citations · 1 hit paper
43 papers, 3.6k citations indexed

About

Eric Ostertag is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Eric Ostertag has authored 43 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Plant Science. Recurrent topics in Eric Ostertag's work include CAR-T cell therapy research (15 papers), Chromosomal and Genetic Variations (14 papers) and CRISPR and Genetic Engineering (11 papers). Eric Ostertag is often cited by papers focused on CAR-T cell therapy research (15 papers), Chromosomal and Genetic Variations (14 papers) and CRISPR and Genetic Engineering (11 papers). Eric Ostertag collaborates with scholars based in United States, China and Japan. Eric Ostertag's co-authors include Haig H. Kazazian, John L. Goodier, Yue Zhang, George L. Gerton, Siew Loon Ooi, Nicolas Gilbert, Wei Wei, Jef D. Boeke, Joseph F. Lawler and John V. Moran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Eric Ostertag

43 papers receiving 3.5k citations

Hit Papers

Biology of Mammalian L1 Retrotransposons 2001 2026 2009 2017 2001 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric Ostertag United States 26 2.9k 2.3k 620 303 260 43 3.6k
Jürg Müller Germany 40 6.3k 2.2× 1.1k 0.5× 936 1.5× 219 0.7× 322 1.2× 75 7.2k
Gunnar Schotta Germany 39 5.6k 1.9× 1.1k 0.5× 829 1.3× 365 1.2× 292 1.1× 77 6.3k
Manfred Schmid Denmark 27 4.1k 1.4× 555 0.2× 343 0.6× 144 0.5× 148 0.6× 45 4.6k
Stéphanie Le Gras France 32 2.0k 0.7× 347 0.2× 437 0.7× 290 1.0× 443 1.7× 57 2.9k
M Fujiwara Japan 33 2.0k 0.7× 1.4k 0.6× 139 0.2× 156 0.5× 706 2.7× 116 3.3k
Mark E. Massari United States 12 1.8k 0.6× 390 0.2× 423 0.7× 217 0.7× 388 1.5× 21 2.5k
Ken-ichi Noma United States 27 4.1k 1.4× 1.6k 0.7× 330 0.5× 151 0.5× 179 0.7× 55 4.7k
Helena Santos-Rosa United Kingdom 20 4.0k 1.4× 423 0.2× 324 0.5× 207 0.7× 196 0.8× 22 4.3k
Valerio Orlando Italy 26 3.3k 1.1× 659 0.3× 507 0.8× 200 0.7× 187 0.7× 51 3.6k
Bing Zhou China 28 2.0k 0.7× 519 0.2× 160 0.3× 210 0.7× 200 0.8× 85 2.9k

Countries citing papers authored by Eric Ostertag

Since Specialization
Citations

This map shows the geographic impact of Eric Ostertag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Ostertag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Ostertag more than expected).

Fields of papers citing papers by Eric Ostertag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Ostertag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Ostertag. The network helps show where Eric Ostertag may publish in the future.

Co-authorship network of co-authors of Eric Ostertag

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Ostertag. A scholar is included among the top collaborators of Eric Ostertag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Ostertag. Eric Ostertag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madison, Blair, Deepak P. Patil, Maximilian Richter, et al.. (2022). Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells. Molecular Therapy — Nucleic Acids. 29. 979–995. 41 indexed citations
2.
Costello, Caitlin, Tara Gregory, Syed Abbas Ali, et al.. (2019). Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME). Blood. 134(Supplement_1). 3184–3184. 43 indexed citations
3.
Noto, Fallon K., Kameswaran Ravichandran, Wei Zhang, et al.. (2018). Sprague Dawley Rag2 -Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts. Molecular Cancer Therapeutics. 17(11). 2481–2489. 15 indexed citations
4.
Wang, Xinxin, Burton E. Barnett, Christopher E. Martin, et al.. (2017). Production of Universal Anti-Bcma CAR-T Cells with Reduced Alloreactivity, but Potent Effector Function for the Treatment of Multiple Myeloma. Blood. 130. 503–503. 3 indexed citations
5.
Ostertag, Eric, Khalil Bdeir, Stephen Kacir, et al.. (2016). ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 2. Pathogenicity in an animal model. Transfusion. 56(7). 1775–1785. 16 indexed citations
7.
Hu, Wenbing, Jian‐Hua Mao, Ruinan Lu, et al.. (2015). High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome. Proceedings of the National Academy of Sciences. 112(31). 9620–9625. 46 indexed citations
8.
Westlund, Karin N., Liping Zhang, Fei Ma, et al.. (2014). A rat knockout model implicates TRPC4 in visceral pain sensation. Neuroscience. 262. 165–175. 35 indexed citations
9.
Huang, Fen, Xidao Wang, Eric Ostertag, et al.. (2013). TMEM16C facilitates Na+-activated K+ currents in rat sensory neurons and regulates pain processing. Nature Neuroscience. 16(9). 1284–1290. 103 indexed citations
10.
Schaefer, Tori L., A Braun, Robyn M. Amos‐Kroohs, et al.. (2012). A new model of Pde4d deficiency: genetic knock‐down of PDE4D enzyme in rats produces an antidepressant phenotype without spatial cognitive effects. Genes Brain & Behavior. 11(5). 614–622. 19 indexed citations
11.
Babushok, Daria V., Kazuhiko Ohshima, Eric Ostertag, et al.. (2007). A novel testis ubiquitin-binding protein gene arose by exon shuffling in hominoids. Genome Research. 17(8). 1129–1138. 39 indexed citations
12.
Ostertag, Eric, Blair Madison, & Hiroki Kano. (2007). Mutagenesis in rodents using the L1 retrotransposon. Genome Biology. 8(Suppl 1). S16–S16. 16 indexed citations
13.
Babushok, Daria V., et al.. (2005). L1 integration in a transgenic mouse model. Genome Research. 16(2). 240–250. 86 indexed citations
14.
Ostertag, Eric, John L. Goodier, Yue Zhang, & Haig H. Kazazian. (2003). SVA Elements Are Nonautonomous Retrotransposons that Cause Disease in Humans. The American Journal of Human Genetics. 73(6). 1444–1451. 265 indexed citations
15.
Meischl, Christof, Eric Ostertag, Martin de Boer, et al.. (2002). Evidence Consistent with Human L1 Retrotransposition in Maternal Meiosis I. The American Journal of Human Genetics. 71(2). 327–336. 95 indexed citations
16.
Ostertag, Eric, Ralph J. DeBerardinis, John L. Goodier, et al.. (2002). A mouse model of human L1 retrotransposition. Nature Genetics. 32(4). 655–660. 159 indexed citations
17.
Wei, Wei, Nicolas Gilbert, Siew Loon Ooi, et al.. (2001). Human L1 Retrotransposition: cis Preference versus trans Complementation. Molecular and Cellular Biology. 21(4). 1429–1439. 493 indexed citations
18.
Ostertag, Eric & Haig H. Kazazian. (2001). Twin Priming: A Proposed Mechanism for the Creation of Inversions in L1 Retrotransposition. Genome Research. 11(12). 2059–2065. 177 indexed citations
19.
Goodier, John L., Eric Ostertag, Kevin Du, & Haig H. Kazazian. (2001). A Novel Active L1 Retrotransposon Subfamily in the Mouse. Genome Research. 11(10). 1677–1685. 170 indexed citations
20.
DeBerardinis, Ralph J., John L. Goodier, Eric Ostertag, & Haig H. Kazazian. (1998). Rapid amplification of a retrotransposon subfamily is evolving the mouse genome. Nature Genetics. 20(3). 288–290. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026